Background: Human papillomavirus (HPV), the causative agent of cervical cancer, can be screened for using self-collected vaginal samples (self-testing). This may overcome barriers to screening for Māori women who suffer a greater burden of cervical disease than New Zealand European women.
INTRODUCTION
In Aotearoa New Zealand, Māori (Indigenous) women suffer a greater burden of cervical disease than New Zealand European (NZE) women.
1, 2 The current National Cervical Screening Programme (NCSP) recommends three-yearly cervical cytology for women aged 20-69 years. 3 The majority of cervical cancers occur in women who have either not received screening or had infrequent screens. 4, 5 Thirty-four percent of Māori women do not attend regular screening, compared to 21% of NZE women. 6 The cost of attending a clinic and perceived invasiveness of a pelvic examination are barriers to screening. 7 These barriers can be compounded for Māori women by services that lack cultural competence. 8 Correspondingly, Māori women are more than twice as likely as NZE women to be diagnosed with, and three times more likely to die from, cervical cancer. 1 This disease is the second leading cause of cancer death for Māori women aged 25-44 years.
9
Upcoming changes to the NCSP include the transition to primary human papilloma virus (HPV) screening on cliniciantaken cervical sample. 10 This test is more effective in detecting pre-cancer changes on the cervix and preventing cervical cancer, than conventional cervical cytology. [11] [12] [13] However, unless currently never/under-screened women take up this new test, cervical cancer incidence and mortality disparities may increase.
Self-collected vaginal specimens (self-testing or self-sampling)
can be used for HPV screening. Recent evidence suggests that vaginal self-obtained samples provide sensitivity and specificity equal to clinician-collected specimens for detecting high-risk HPV types and cervical intraepithelial neoplasia 2+. 14 HPV self-testing acceptability, feasibility and satisfaction studies among Indigenous and ethnic minority women found that HPV self-testing is preferable to cervical cytology, and potentially eliminates barriers to cervical screening. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] To date, there are no studies published about HPV self-testing for Māori women. This paper describes a Kaupapa Māori (by, with, and for Māori) 27 study that explored the potential acceptability of HPV self-testing for never/under-screened Māori women. The objectives were to explore: never/under-screened Māori women's perspectives on HPV self-testing through face-to-face hui (focus groups and interviews; objective 1) and survey (objective 2), and healthcare provider (HCP) advice about HPV self-testing (objective 3).
MATERIALS AND METHODS
The study gained ethics approval from the Northern B Health 
Healthcare providers
The final data collection involved hui with (Māori and non-Māori)
HCPs, including smear/sample takers, general practitioners, nurses, clinic staff and cytologists, in two urban centres. HCPs were asked their views on cervical screening and HPV self-testing.
HCP hui data were also analysed thematically using NVivo.
RESULTS
One hundred and six eligible women participated in hui (South Auckland, 27; Christchurch, 25; Northland, 20; Tairāwhiti, 34).
Three hundred and ninety-seven eligible women completed the survey (South Auckland, 116; Christchurch, 100; Northland, 79;
Tairāwhiti, 96; other residence given, six). Seventeen HCPs participated in hui (Christchurch, eight; Wellington, nine).
Engagement with health services
Just over half the survey respondents (54.91%) were in the 25-39 years age group; most were enrolled with a PHO (87.15%) and attended regularly (71.79%). Half were four to five years past their last cervical screen (50.88%). One in seven (14.36%) had not screened in ten years or more (including those never screened), and one in six (16.37%) were unsure how long it had been since their last cervical screen (Table 1) .
Barriers to screening
Women in the hui most frequently referred to a desire for bodily autonomy (retaining privacy, control over one's body) as a reason for not attending regular cervical screening. This encompasses concepts of whakamā (embarrassment/shyness/reticence), and tapu (sacred/taboo/forbidden). The desire for bodily autonomy was often related to negative health experiences (eg, painful pelvic examinations, inappropriate actions/comments by HCPs).
'Whakamā' was the most common survey reason for not attending regular cervical screening. A lack of time and fear of discomfort or pain were also common reasons. Older women were more likely to mention a previous bad experience and were less likely than younger women to mention cost or other financial barriers (Table 2 ).
HCPs spoke of shyness/embarrassment being a major barrier, especially for younger women. Opinions varied about cost being a barrier (as many clinics offer free cervical screening). Some highlighted hidden costs (transport, parking, childcare). A lack of health literacy about HPV and cervical cancer and a lack of appropriate/empathetic services were also raised as barriers.
Acceptability
Hui participant responses to the idea of HPV self-testing were generally very positive, with participants using terms such as 'easier', 'more comfortable', 'less intrusive' and 'brilliant'. Areas identified This question allowed respondents to choose as many options as they liked, so the column percentages do not add up to 100. HCPs agreed that with appropriate support and education, HPV self-testing will benefit never/under-screened Māori.
Implementation
Hui participants suggested picking up the HPV self-test from a clinic, a pharmacy or other community venue, or receiving it by post/mail. The most frequently discussed means of getting a completed self-test kit (with sample inside) to a lab were dropping the kit off to a clinic or lab, or sending it by prepaid post or courier. However, concerns were raised about the reliability of post.
Participants discussed the value of providing multiple options.
Nearly two-thirds of women surveyed said they would be happy to receive an HPV self-test kit by post. Having the kit delivered by a community health worker was popular for 40-54-year-olds, while picking up a kit from a clinic was popular with those aged 55+. Receiving a self-test kit by post or picking it up from a pharmacy/chemist were less popular options with women who had not screened in ten or more years or ever.
Compared with rural women, urban women were more in favour of receiving a self-test kit by post and less in favour of picking one up from a clinic ( Table 3) .
Half of the survey participants said they would like to return their sample to the lab by prepaid post/courier, and half said they could drop it at a clinic. Women aged 55+ years were less likely to choose the post or community health worker pickup. Women not PHO-enrolled/unsure were less likely to choose to drop it at This question allowed respondents to choose as many options as they liked, so the column percentages do not add up to 100. A small number of women reported being unsure of how they would want to receive the human papilloma virus self-test kit (n = 24, 6%), or how they would want to return the completed kit to the lab (n = 19, 5%). a health clinic or pharmacy/chemist. For women who had not screened in ten or more years or ever, post and dropping the sample at a clinic or pharmacy/chemist were less popular options. Rural women were less likely than urban women to say they would use the post to return their sample to the lab, and more likely to say they would drop it at a clinic (Table 3) .
F I G U R E 1 Preferences regarding HPV testing (N = 397
HCPs debated the efficacy of a post/mail-out system for HPV self-testing. Criticisms included referencing previous mail-out screening failures, mobile populations, an outdated post system, and a preference for women to be supported to do the test in an organised setting. Others argued that if women are already not visiting a clinic for a cervical screen, it might be difficult to get them there for a self-test. Flexibility to cater to diverse populations, such as through community outreach services, was suggested for optimum engagement.
Doing the HPV self-test
Hui participants most frequently said they would be happy to do the HPV self-test in a clinic or their own home, and emphasised having good support and education to increase their confidence about properly doing it. Participants highlighted the need for a flexible program, with different options.
More than three-quarters of women surveyed (77.83%) said they would be happy to do an HPV self-test in their own home, and almost one-third (29.22%) said they would be happy to do it in a clinic. Urban women were more likely (than rural) to say they would self-test at a community centre. More than half of survey participants (58.69%) said they did not want any support while self-testing. One in five said they would like whānau/family or friends to be around in case they needed help, while some (<15%) said they would like either a community health worker or health practitioner to be nearby, available to help.
HCPs talked about the importance of delivering empathetic cervical screening services, ie 'the process' -taking the time to put mind and body at ease. They emphasised that this process will be important for any new HPV-based cervical screening program.
HPV self-test results
In the hui, differences in preferences for finding out about results were often explained as being dependent on the results, However, care will need to be taken to ensure that those women who feel less confident to undergo cytology or colposcopy, such as those who are currently not PHO-enrolled/unsure or who have not screened in ten or more years or ever, are supported.
The majority of Māori women in this study were engaged in the health system, but did not screen. This is a system failure.
The findings suggest that HPV self-testing could be very acceptable for Māori women who find current screening unacceptable.
Recommendations for a culturally competent HPV self-testing cervical cancer prevention program include: a strengths-based whānau approach to HPV education, empathetic delivery of services, and flexibility -PHOs working closely with community health providers to ensure standard recall, opportunistic in-clinic invitations to selftest, and targeted outreach.
Limitations
The study relied on self-reporting of last cervical screen, with potential for inaccuracies. However, other research indicates that it is more likely that participants incorrectly report that they have screened, rather than incorrectly report that they have not screened. 33 Although possibly not generalisable, the number of participants and the geographic coverage signal that the findings are a good representation of never/under-screened Māori women's views on the potential acceptability of HPV self-testing. However, limited information was gathered from women who said they would refuse the HPV self-test.
Strength
A large number of never/under-screened Māori women participated in this research, largely because community-based researchers used their networks to access typically considered 'hard-to-reach' women.
CONCLUSION
The findings indicate that with a culturally competent introduction of HPV self-testing, many currently never/under-screened Māori women would be willing to be screened, and followed up if necessary. HPV self-testing has the potential to save lives.
